217 filings
Page 3 of 11
8-K
zb7tku6e18rjjmew h3v
28 Jul 22
Novocure Reports Second Quarter 2022 Financial Results
7:03am
8-K
i2w nwn7so9
10 Jun 22
Departure of Directors or Certain Officers
4:15pm
8-K
kvfaplqnw5m 5ujf
3 Jun 22
Regulation FD Disclosure
8:01am
8-K
k9ay0h w18tc
26 May 22
Entry into a Material Definitive Agreement
8:04am
8-K
t5871g4jghwk
28 Apr 22
Novocure Reports First Quarter 2022 Financial Results
7:04am
DEFA14A
zqr2 iw4ybxcozq9tr
25 Apr 22
Additional proxy soliciting materials
4:16pm
8-K
tye8q7ame27 bmvix9
13 Apr 22
Departure of Directors or Certain Officers
4:06pm
8-K
mkkrylow5 yu6
7 Apr 22
Other Events
4:07pm
8-K
8tzd8m6eo8z
23 Mar 22
Novocure Announces Favorable Recommendation to Continue the Phase 3 Pivotal INNOVATE-3 Study of Tumor Treating Fields in Ovarian Cancer
8:01am
S-8
8ilgmy ad58c
24 Feb 22
Registration of securities for employees
4:03pm
8-K
mtm9yiizm6 ldq0xe14s
24 Feb 22
Novocure Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update
7:00am
8-K
0ll z1bllkwbwt2ct3g
10 Jan 22
Novocure Announces Preliminary Full Year and Fourth Quarter 2021 Net Revenues and Provides Company Update
7:05am
8-K
imyg68tn665dor5891n
30 Dec 21
Other Events
4:05pm
8-K
t1w1 ctbj
7 Dec 21
Novocure Signs Agreement to Acquire and Construct Building in Downtown Portsmouth, New Hampshire
4:01pm